Kawasaki Syndrome Treatment in Hospitals in Incheon, South Korea

Kawasaki syndrome, or mucocutaneous lymph node syndrome – is a rare and specific disease diagnosed primarily in infants and children under 5 years old. The pathology destroys vessels, promotes the formation of aneurysms, and catalyzes thrombosis. Medics lean towards an infectious etiology of the disease, however, the true and exact causes have not been fully elucidated. Kawasaki syndrome treatment in Incheon helps neutralize symptoms, stop the disease progression and protect the child''s body from characteristic complications.

Due to the low prevalence of the disease, it is quite difficult to diagnose. Doctors of clinics in Incheon draw up special programs for babies with congenital pathologies. In differentiating the syndrome, laboratory tests, ECG, plain digital chest X-ray, CT and MRI on wide-field tomographs with a power of 3-9 Tesla, MSCT, scintigraphy are used.

When treating Kawasaki syndrome in Incheon, the following drugs are used:

• non-steroidal anti-inflammatory drugs,
• immunoglobulins,
• corticosteroids,
• angioprotectors,
• TNF-alpha blockers.

The drugs belong to the new generation and are highly effective. Along with them, procedures of interventional endovascular surgery, plasmapheresis, open surgery on vessels can be performed.

Unfortunately, Kawasaki syndrome cannot be cured completely, but medics in Incheon demonstrate significant success in achieving stable remission. Before discharge, doctors give parents or guardians recommendations regarding maintaining the effect and controlling the pathology in the future.